Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The national COPD screening program is in a cross-sectional manner at the baseline, planning to recruit a total of 800,000 participants from 160 districts or counties (5,000 for each site on average) from 31 provinces, autonomous regions or municipalities directly under the central government of China. The filtered COPD high-risk population and confirmed COPD patients will be managed and followed up according to the standardized clinical guidelines. The major aims of the program are to estimate the prevalences of COPD high-risk population and under- or miss- diagnosed COPD patients, and to manage the development and outcomes of the disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Non-COPD high-risk population | The local residents gain a COPD-SQ score < 16. |
| |
| COPD high-risk population | The participants have a COPD-SQ score ≥ 16 with a FEV1/FVC ≥ 0.70 either with or without bronchodilator administration. |
| |
| Confirmed COPD patients | The participants have a COPD-SQ score ≥ 16 with a FEV1/FVC ≥ 0.70 after administration of bronchodilators. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Comprehensive intervention and management Ⅰ | Other | Mainly health advisory. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Lung function | The changes of lung function (e.g. FEV1, FVC, FEV1/FVC, etc.) (P.S.: it is hard to assume that the lung function would be improved or decling, especially for the pre- or early-COPD population) | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Respiratory symptoms | The appearance frequencies of respiratory symptoms (e.g. cough, sputum, wheeze, dyspnea, etc.) | 2 years |
| Exacerbations | The numbers of exacerbations (e.g. emergency department visit, hospital admission, etc.) that related to COPD |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Adults who are potentially under a high risk of suffering COPD with an age between 35 and 75 years are eligible to be recruited. The participants should be residents who were living in the survey area with more than six months in the past year.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jieping LEI, Ph.D. | Contact | 010-84206408 | jiepinglei@126.com |
| Name | Affiliation | Role |
|---|---|---|
| Ting YANG, M.D. | China-Japan Friendship Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| China-Japan Friendship Hospital | Recruiting | Beijing | China |
Data would be available on reasonable request from the principal investigator.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Comprehensive intervention and management Ⅱ | Other | Health advisory and regular follow-ups. |
|
| Comprehensive intervention and management Ⅲ | Other | Pharmaceutical and non-pharmaceutical (e.g. health advisory, rehabilitation, etc.) interventions according to standardized clinical guidelines, with regular follow-ups. |
|
| 2 years |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |